Shortened Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Contemporary Clinical Review
Interventional Cardiology: Reviews, Research, Resources · 11.12.2023 · 18
DOI: 10.15420/icr.2023.19 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Interventional Cardiology: Reviews, Research, Resources, online erschienen am 11.12.2023. Verfasst von Kevin S Tang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Internal Medicine, Department of Medicine, University of California Irvine Health Orange, CA, US. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Percutaneous coronary intervention with stent implantation is an integral aspect of minimally interventional cardiac procedures. The technology and techniques behind stent design and implantation have evolved rapidly over several decades. However, continued discourse remains around optimal peri- and post-interventional management with dual antiplatelet therapy to minimise both major cardiovascular or cerebrovascular events and iatrogenic bleeding risk. Standard guidelines around dual antiplatelet therapy historically recommended long-term dual antiplatelet therapy for 12 months (with consideration for >12 months in certain patients); however, emerging data and generational improvements in the safety of drug-eluting stents have ushered in a new era of short-term therapy to reduce the incidence of major bleeding events. This case review will provide an overview of the current state of guidelines around duration of dual antiplatelet therapy and examine recent updates and continued gaps in existing research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Internal Medicine, Department of Medicine, University of California Irvine Health Orange, CA, US.
- Division of Cardiology, Department of Medicine, University of California Irvine Health Orange, CA, US.
Zitieren
APA
Tang, K. S., Banerjee, S., Tang, G., Patel, P. M., & Frangieh, A. H. (2023). Shortened Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Contemporary Clinical Review. Interventional Cardiology: Reviews, Research, Resources, 18. https://doi.org/10.15420/icr.2023.19
Vancouver
Tang KS, Banerjee S, Tang G, Patel PM, Frangieh AH. Shortened Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Contemporary Clinical Review. Interventional Cardiology: Reviews, Research, Resources. 2023;18. doi:10.15420/icr.2023.19
BibTeX
@article{Tang2023,
author = {Tang, Kevin S and Banerjee, Shoujit and Tang, George and Patel, Pranav M and Frangieh, Antonio H},
title = {Shortened Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Contemporary Clinical Review},
journal = {Interventional Cardiology: Reviews, Research, Resources},
year = {2023},
volume = {18},
doi = {10.15420/icr.2023.19}
}
EUVIMED